1. Home
  2. DARE vs SWIN Comparison

DARE vs SWIN Comparison

Compare DARE & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • SWIN
  • Stock Information
  • Founded
  • DARE 2015
  • SWIN 2017
  • Country
  • DARE United States
  • SWIN Hong Kong
  • Employees
  • DARE N/A
  • SWIN N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • DARE Health Care
  • SWIN
  • Exchange
  • DARE Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • DARE 26.3M
  • SWIN 214.1M
  • IPO Year
  • DARE N/A
  • SWIN 2023
  • Fundamental
  • Price
  • DARE $2.48
  • SWIN $3.80
  • Analyst Decision
  • DARE Strong Buy
  • SWIN
  • Analyst Count
  • DARE 3
  • SWIN 0
  • Target Price
  • DARE $12.50
  • SWIN N/A
  • AVG Volume (30 Days)
  • DARE 4.6M
  • SWIN 216.6K
  • Earning Date
  • DARE 08-11-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • DARE N/A
  • SWIN N/A
  • EPS Growth
  • DARE N/A
  • SWIN N/A
  • EPS
  • DARE N/A
  • SWIN N/A
  • Revenue
  • DARE $25,909.00
  • SWIN $3,316,000.00
  • Revenue This Year
  • DARE $74,787.57
  • SWIN $29.79
  • Revenue Next Year
  • DARE $141.76
  • SWIN $54.60
  • P/E Ratio
  • DARE N/A
  • SWIN N/A
  • Revenue Growth
  • DARE N/A
  • SWIN N/A
  • 52 Week Low
  • DARE $2.11
  • SWIN $1.16
  • 52 Week High
  • DARE $9.19
  • SWIN $4.40
  • Technical
  • Relative Strength Index (RSI)
  • DARE 43.58
  • SWIN 59.60
  • Support Level
  • DARE $2.44
  • SWIN $3.29
  • Resistance Level
  • DARE $2.80
  • SWIN $3.99
  • Average True Range (ATR)
  • DARE 0.66
  • SWIN 0.39
  • MACD
  • DARE 0.01
  • SWIN -0.04
  • Stochastic Oscillator
  • DARE 5.23
  • SWIN 80.93

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

Share on Social Networks: